SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sai Life Sciences informs about disclosure

21 Feb 2025 Evaluate

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’), Sai Life Sciences has informed that an Order was passed by the Deputy Commissioner of Commercial Taxes (Audit), Bidar, Karnataka on 20 February 2025, raising a demand including interest and penalty on the Company. The details as required in terms of Regulation 30 read with sub-para 20 of Para A and sub-para 8 of Para B of Part A of Schedule III of the Listing Regulations is enclosed as Annexure - I.

The above information is a part of company’s filings submitted to BSE.

Sai Life Sciences Share Price

958.30 -12.20 (-1.26%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×